NCT06524557 Exploration of Noninvasive Differential Diagnosis of Benign and Malignant Liver Tumors
| NCT ID | NCT06524557 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xijing Hospital |
| Condition | Liver Tumor |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2018-01-01 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2018-01-01 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To explore an effective noninvasive method for differential diagnosis of liver tumors.
Eligibility Criteria
Inclusion Criteria: (1) age 18-70 years; (2) liver examination performed for all patients prior to US-guided liver biopsy or surgery; (3) tumor can be visualized in conventional US; (4) largest tumor sectional area saved in DICOM format for use in later analyses; (5) a histopathological diagnosis made either from US-guided liver biopsy or surgical resection; (6) suitable routine clinical and US data obtained within 7 days of the histopathological diagnosis. Exclusion Criteria: (1) unavailable pathological diagnosis; (2) liver metastatic tumors; (3) poor quality US images; and (4) a past history of surgical resection, percutaneous local ablation, radiation, transarterial and systemic therapies or liver transplantation.
Contact & Investigator
Zhou Huihui, M.M.
STUDY CHAIR
Department of Ultrasonic Medicine, The First Affiliated Hospital of Air Force Medical University
Frequently Asked Questions
Who can join the NCT06524557 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Liver Tumor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06524557 currently recruiting?
Yes, NCT06524557 is actively recruiting participants. Contact the research team at huihui2807201830@163.com for enrollment information.
Where is the NCT06524557 trial being conducted?
This trial is being conducted at Xi'an, China.
Who is sponsoring the NCT06524557 clinical trial?
NCT06524557 is sponsored by Xijing Hospital. The principal investigator is Zhou Huihui, M.M. at Department of Ultrasonic Medicine, The First Affiliated Hospital of Air Force Medical University. The trial plans to enroll 200 participants.